Certara’s Best of the Blog 2017

A selection of short essays from our blog, written to empower our customers with modeling and simulation (M&S) and regulatory writing solutions in order to help them solve the toughest drug development problems. Certara staff contributions range in topic from pharmacometrics to systems biology to the growing importance of regulatory writing and sharing clinical trial results.

Read More
Topics:

Certara Launches Version 10 of D360, Its Industry-leading Drug Discovery Informatics Platform

PRINCETON, NJ – Feb. 14, 2018 – Certara today announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions.

Read More
Topics:

Agile Access to Drug Discovery Data with D360

D360 makes it easy for all project team members to access standard discovery project data views or perform exploratory analyses. This webinar focuses on utilizing D360 to get the most out of drug discovery data by utilizing simple query-building with integrated chemistry tools and analysis tools, dynamically linked data visualizations and easy to use annotations. […]

Read More
Topics:

D360 Pre-clinical

D360 removes the major roadblocks that preclinical scientists encounter when answering questions related to safety data by making the data easily available, in a format that is readily accessible and usable. As a result, answers are arrived at quickly and easily, and scientists are enabled to ask questions that were previously impossible to ask.

Read More
Topics:

D360 IT Maintenance Overhead

Providing scientists with access to project data and tools to analyze and collaborate is vitally important to improving the effectiveness of rational, data-driven research. This capability must be provided without undue burden or cost on already stretched IT resources. D360™ is a scientific informatics tool that meets these criteria.

Read More
Topics:

Cross-Study Search and Analysis of Pre-clinical Safety Data

Certara’s D360 enables scientists to focus on uncovering trends in their data, without the pain of figuring out how to access it. A global top 10 pharmaceutical company, devoted to discovering new medicines and new technologies for managing personal health, engaged in an initiative to better address cross-study analysis of pre-clinical safety data. Toxicologists, pathologists, […]

Read More
Topics:

Streamlined, Self-Service Access to Scientific Data

D360 enables scientists to easily access, analyze, and visualize chemical and biological data, enhance scientific capabilities. A small biotechnology company dedicated to the research and development of small molecule therapeutics engaged in an initiative to better address access and analysis of chemical and biological data by its scientists. Scientists at this company use IDBS’ ActivityBase®, […]

Read More
Topics:

Optimized Pre-clinical Informatics for Faster, Surer Development Decisions

A top 40 pharmaceutical company enhanced data access and decision support for pre-clinical safety with Certara’s D360 data access and analysis application and a specialized CDISC SEND-based database. Pre-clinical scientists at a top 40 pharmaceutical company faced delays of a day or more for data collation and transformation with each incremental data update received from […]

Read More
Topics:

Replacing In-House Informatics for Cost Savings and Enhanced Knowledge Access

Discovery team lowers IT costs and improves end-user functionality by standardizing on Certara’s D360 Drug Discovery Platform A multi-national pharmaceutical company had developed a custom informatics system, providing all scientists in its discovery organization with access to essential research data. While information access was well-served by the tool, over time, a long list of new […]

Read More
Topics:

Analyses Requiring Hours In The Past Reduced To Minutes

Medivir sees a fast return on its investment — time savings and enhanced informativeness of data activities The discovery arm of Medivir®, a mid-size, Swedish pharmaceutical company, sought an updated informatics infrastructure to improve the efficiency and flexibility of its data analysis and reporting. The group’s existing in-house tools could only create reports in a […]

Read More
Topics:

Speeding the Iterative Drug Design process

In this paper, we explore the issues in the effective use of modern pharmaceutical data mining applications. We discuss the development and capabilities that were built into the Discovery 360° application to address these issues, as part of Wyeth Pharmaceuticals Next Generation IT project (NextGen). Wyeth found that simplifying data access and integration of data […]

Read More
Topics:

Certara Reinforces D360’s Position as Dominant Big Data Platform for the Biopharmaceutical Industry

D360 version 8.0 supports connections to broader and more diverse data sets, increases collaboration across silos, and delivers faster time to insight for scientific decision making PRINCETON, NJ – Feb. 17, 2015 – Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it will be launching version 8.0 of […]

Read More
Topics:
Learn More LinkedIn Twitter Facebook Email